HealthStream Inc HSTM.OQ HSTM.O is expected to show a rise in quarterly revenue when it reports results for the period ending June 30 2025
The Nashville Tennessee-based company is expected to report a 4.0% increase in revenue to $74.393 million from $71.56 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for HealthStream Inc is for earnings of 16 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for HealthStream Inc is $34.50, about 21.6% above its last closing price of $27.04
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | 0.15 | 0.16 | 0.14 | Missed | -10.3 |
Dec. 31 2025 | 0.17 | 0.14 | 0.16 | Beat | 14.3 |
Sep. 30 2024 | 0.13 | 0.13 | 0.19 | Beat | 51.8 |
Jun. 30 2024 | 0.13 | 0.12 | 0.14 | Beat | 18 |
Mar. 31 2024 | 0.11 | 0.11 | 0.17 | Beat | 56 |
Dec. 31 2023 | 0.11 | 0.10 | 0.15 | Beat | 47.5 |
Sep. 30 2023 | 0.09 | 0.09 | 0.13 | Beat | 51.2 |
Jun. 30 2023 | 0.08 | 0.09 | 0.13 | Beat | 51.2 |
This summary was machine generated July 18 at 11:19 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)